Preconception thyroid‐stimulating hormone levels and adverse pregnancy outcomes
Clinical Endocrinology Jan 05, 2022
Li M, He Y, Mao Y, et al. - Researchers aimed at ascertaining if subclinical thyroid dysfunction before conception is associated with adverse pregnancy outcomes.
Retrospective cohort study of 50,217 women without prior thyroid disease who became pregnant within 1 year after undertaking a routine TSH test.
Composite adverse pregnancy outcomes (CAPO), comprising pregnancy loss, small for gestational age, large for gestational age, and preterm birth, were reported in 24.19%.
Preconception TSH levels and pregnancy outcomes were identified to exhibit non-linear associations.
Risk for CAPO appeared higher among women with subclinical hypothyroidism before conception, while a higher risk of preterm delivery was recorded for those with subclinical hyperthyroidism.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries